AAAAAA

   
Results: 1-14 |
Results: 14
10 YEARS EXPERIENCE OF SIMVASTATIN TREATMENT IN MARKED HYPERCHOLESTEROLEMIA
Authors: OLSSON AG MOLGAARD J
Citation: Ag. Olsson et J. Molgaard, 10 YEARS EXPERIENCE OF SIMVASTATIN TREATMENT IN MARKED HYPERCHOLESTEROLEMIA, Journal of the American College of Cardiology, 31(2), 1998, pp. 319-319
UNILATERAL VOCAL CORD PARALYSIS FOLLOWING ENDOTRACHEAL INTUBATION
Authors: LAURSEN RJ LARSEN KM MOLGAARD J KOLZE V
Citation: Rj. Laursen et al., UNILATERAL VOCAL CORD PARALYSIS FOLLOWING ENDOTRACHEAL INTUBATION, Acta anaesthesiologica Scandinavica, 42(1), 1998, pp. 131-132
PLASMA-LIPOPROTEIN ABNORMALITIES AND APOLIPOPROTEIN-E PHENOTYPES IN INTERMITTENT CLAUDICATION - A MULTIVARIATE-ANALYSIS OF RANDOMLY SELECTED SUBJECTS
Authors: MOLGAARD J VONSCHENCK H KUUSI T HOLME I LASSVIK C TASKINEN MR OLSSON AG
Citation: J. Molgaard et al., PLASMA-LIPOPROTEIN ABNORMALITIES AND APOLIPOPROTEIN-E PHENOTYPES IN INTERMITTENT CLAUDICATION - A MULTIVARIATE-ANALYSIS OF RANDOMLY SELECTED SUBJECTS, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 6(3), 1996, pp. 114-123
COPPER-INDUCED LOW-DENSITY-LIPOPROTEIN OXIDATION IS NOT A RISK DISCRIMINATOR FOR INTERMITTENT CLAUDICATION
Authors: ZIEDEN B MOLGAARD J OLSSON AG
Citation: B. Zieden et al., COPPER-INDUCED LOW-DENSITY-LIPOPROTEIN OXIDATION IS NOT A RISK DISCRIMINATOR FOR INTERMITTENT CLAUDICATION, VASA, 25(2), 1996, pp. 121-126
THE EFFECT OF PROBUCOL ON LOW-DENSITY-LIPOPROTEIN OXIDATION AND FEMORAL ATHEROSCLEROSIS
Authors: REGNSTROM J WALLDIUS G NILSSON S ELINDER LS JOHANSSON J MOLGAARD J HOLME I OLSSON AG NILSSON J
Citation: J. Regnstrom et al., THE EFFECT OF PROBUCOL ON LOW-DENSITY-LIPOPROTEIN OXIDATION AND FEMORAL ATHEROSCLEROSIS, Atherosclerosis, 125(2), 1996, pp. 217-229
LOWERING OF HDL(2B) BY PROBUCOL PARTLY EXPLAINS THE FAILURE OF THE DRUG TO AFFECT FEMORAL ATHEROSCLEROSIS IN SUBJECTS WITH HYPERCHOLESTEROLEMIA - A PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST) REPORT
Authors: JOHANSSON J OLSSON AG BERGSTRAND L ELINDER LS NILSSON S ERIKSON U MOLGAARD J HOLME I WALLDIUS G
Citation: J. Johansson et al., LOWERING OF HDL(2B) BY PROBUCOL PARTLY EXPLAINS THE FAILURE OF THE DRUG TO AFFECT FEMORAL ATHEROSCLEROSIS IN SUBJECTS WITH HYPERCHOLESTEROLEMIA - A PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST) REPORT, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1049-1056
PROBUCOL TREATMENT DECREASES SERUM CONCENTRATIONS OF DIET-DERIVED ANTIOXIDANTS
Authors: ELINDER LS HADELL K JOHANSSON J MOLGAARD J HOLME I OLSSON AG WALLDIUS G
Citation: Ls. Elinder et al., PROBUCOL TREATMENT DECREASES SERUM CONCENTRATIONS OF DIET-DERIVED ANTIOXIDANTS, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1057-1063
PREDILECTION OF ATHEROSCLEROSIS FOR THE INNER CURVATURE IN THE FEMORAL-ARTERY - A DIGITIZED ANGIOGRAPHY STUDY
Authors: SMEDBY O JOHANSSON J MOLGAARD J OLSSON AG WALLDIUS G ERIKSON U
Citation: O. Smedby et al., PREDILECTION OF ATHEROSCLEROSIS FOR THE INNER CURVATURE IN THE FEMORAL-ARTERY - A DIGITIZED ANGIOGRAPHY STUDY, Arteriosclerosis, thrombosis, and vascular biology, 15(7), 1995, pp. 912-917
THE RELATION OF CORONARY AND PERIPHERAL ARTERIAL-DISEASE TO THE SEVERITY OF FEMORAL ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIA
Authors: BERGSTRAND L OLSSON AG ERIKSON U HOLME I JOHANSSON J KAIJSER L LASSVIK C MOLGAARD J NILSSON S STENPORT G WALLDIUS G
Citation: L. Bergstrand et al., THE RELATION OF CORONARY AND PERIPHERAL ARTERIAL-DISEASE TO THE SEVERITY OF FEMORAL ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIA, Journal of internal medicine, 236(4), 1994, pp. 367-375
SERUM LIPID-SOLUBLE ANTIOXIDANTS IN PATIENTS WITH HYPERLIPOPROTEINEMIA
Authors: ELINDER LS HADELL K JOHANSSON J MOLGAARD J OLSSON AG WALLDIUS G
Citation: Ls. Elinder et al., SERUM LIPID-SOLUBLE ANTIOXIDANTS IN PATIENTS WITH HYPERLIPOPROTEINEMIA, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(4), 1994, pp. 197-203
THE EFFECT OF PROBUCOL ON FEMORAL ATHEROSCLEROSIS - THE PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST)
Authors: WALLDIUS G ERIKSON U OLSSON AG BERGSTRAND L HADELL K JOHANSSON J KAIJSER L LASSVIK C MOLGAARD J NILSSON S SCHAFERELINDER L STENPORT G HOLME I
Citation: G. Walldius et al., THE EFFECT OF PROBUCOL ON FEMORAL ATHEROSCLEROSIS - THE PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST), The American journal of cardiology, 74(9), 1994, pp. 875-883
THE EFFECT OF PROBUCOL ON FEMORAL ATHEROSCLEROSIS - THE PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST)
Authors: WALLDIUS G ERIKSON U OLSSON AG BERGSTRAND L HADELL K JOHANSSON J KAIJSER L LASSVIK C MOLGAARD J NILSSON S SCHAFERELINDER L STENPORT G HOLME I
Citation: G. Walldius et al., THE EFFECT OF PROBUCOL ON FEMORAL ATHEROSCLEROSIS - THE PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST), The American journal of cardiology, 74(9), 1994, pp. 875-883
REPRODUCIBILITY OF QUANTITATIVE ARTERIOGRAPHIC ASSESSMENT OF ATHEROSCLEROSIS IN THE FEMORAL-ARTERY
Authors: BERGSTRAND L ERIKSON U HOLME I JOHANSSON J OLSSON AG MOLGAARD J NILSSON S STENPORT G WALLDIUS G
Citation: L. Bergstrand et al., REPRODUCIBILITY OF QUANTITATIVE ARTERIOGRAPHIC ASSESSMENT OF ATHEROSCLEROSIS IN THE FEMORAL-ARTERY, Acta radiologica, 34(6), 1993, pp. 612-617
HYPERHOMOCYST(E)INAEMIA - AN INDEPENDENT RISK FACTOR FOR INTERMITTENTCLAUDICATION
Authors: MOLGAARD J MALINOW MR LASSVIK C HOLM AC UPSON B OLSSON AG
Citation: J. Molgaard et al., HYPERHOMOCYST(E)INAEMIA - AN INDEPENDENT RISK FACTOR FOR INTERMITTENTCLAUDICATION, Journal of internal medicine, 231(3), 1992, pp. 273-279
Risultati: 1-14 |